Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions
Precise pharmacokinetic data for BPC-157 in humans does not exist in peer-reviewed literature
The options may be chosen on the product page R450.00 This product has multiple variants
Long-Term Safety Considerations: While safety data from clinical trials spanning up to 24 weeks is reassuring, long-term safety data spanning years of continuous use remains limited
Standard Insulin Syringe Capacities 0.3 mL Syringe: 30 units max ideal for small, precise doses under 30 units
US$ 25.15
US$ 24.64
US$ 25.56
US$ 21.42
